INTRODUCTION {#S1}
============

The recent re-discovery of human brown adipose tissue (BAT) ([@R1]--[@R4]) has triggered intense scientific interest in the potential of this tissue as a target against obesity and its metabolic abnormalities. Numerous studies investigated the origin, plasticity, and metabolic characteristics of this tissue in animals (reviewed at ([@R5])). However, these findings must be translated into humans in order for any therapeutic value to be realized. Currently, only a handful of studies have reported data from human BAT ([@R1], [@R2], [@R4], [@R6]--[@R15]) primarily using samples collected during surgeries ([@R2], [@R4], [@R6]), necropsies ([@R7], [@R12], [@R14]) or using an open biopsy technique ([@R1], [@R8], [@R9], [@R13]).

Hampering the effort to study the biology of human BAT is the lack of a safe method for the routine sampling of this tissue for research purposes. The Bergström needle has long been used for non-image guided biopsy of muscles/soft tissues ([@R16]), while computed tomography (CT)-guided biopsy technique is well known and refined over the past 30 years for all types of tissues ([@R17]). The purpose of this report is to describe a novel positron emission tomography (PET) and CT-guided Bergström needle technique to sample supraclavicular human BAT deposit.

METHODS {#S2}
=======

Supraclavicular BAT biopsies were obtained from healthy participants enrolled in clinical studies at the University of Texas Medical Branch at Galveston. Eligible participants underwent the supraclavicular biopsy procedure at least once. Informed written consent was obtained prior to inclusion in the studies from all participants in accordance with the Declaration of Helsinki. The Institutional Review Board and the Institute for Translational Science Scientific Review Committee at the University of Texas Medical Branch approved the experimental protocol.

After 2-6h of non-shivering cold exposure ([@R10]), a bolus injection of 185 MBq of 2-deoxy-2-\[18F\]fluoroglucose (^18^F-FDG) was administered to participants. Cold was used as a stimulus to activate BAT thermogenesis and ^18^F-FDG uptake in BAT. One hour later, a PET/CT scan (General Electric Medical Systems, Milwaukee, WI) was performed to visualize supraclavicular BAT using the ^18^F-FDG-PET/CT images ([Figure 1a](#F1){ref-type="fig"}).

Participants were transferred to the CT procedure room ([Figure 1b](#F1){ref-type="fig"}) and scout images of the lower neck ([Figure 1c](#F1){ref-type="fig"}) were taken to visualize the anatomy of the supraclavicular area (General Electric Medical Systems, Milwaukee, WI). Using major anatomical landmarks, an experienced interventional radiologist (P.A.), identified the location of the supraclavicular BAT depot in the CT images corresponding to the BAT in the PET/CT scan. Then, the skin over the area of the biopsy was thoroughly cleaned using chlorhexidine and covered with a sterile drape. A small amount (2--5 mL) of 2% lidocaine was injected in the dermis of the biopsy site and in the subcutaneous adipose tissue depot. The injection needle was advanced in the targeted adipose tissue area and an additional CT scan was performed to ensure the correct placement of the needle at the biopsy cite, avoiding any adjacent superficial veins ([Figure 1c](#F1){ref-type="fig"}). Subsequent measures were taken to determine the depth of the BAT deposit and the advancement of the biopsy needle.

Afterwards, an incision was made in the skin (\<1cm) using a scalpel and a 6 mm Bergström needle (Stille, Lombard, IL) was inserted through the incision and advanced into the supraclavicular adipose tissue depot. Once the needle was positioned appropriately, a trained member of the research team applied suction using a 60 mL syringe and a suction catheter ([Figure 1d](#F1){ref-type="fig"}). Precooled bacitracin ointment was applied to the top of the inner cannula to maintain suction and avoid leakage of air between the needle and the inner cannula. The needle was rotated 180° and the target depot was sampled. The procedure ([Figure 1e](#F1){ref-type="fig"}) was repeated up to three times. Once the biopsy procedure was over, we applied manual compression for 3--5 min to minimize bleeding. Subsequently, the incision was closed using standard 2.0 silk sutures and a sterile dressing was applied. The duration of the BAT biopsy procedure was \~30--40 min.

The participants were instructed to avoid swimming and rigorous exercise for the first 72h after the biopsy. Further, they were instructed to inspect the wound daily, apply antibiotic ointment once or twice a day and take painkillers for discomfort as needed. The participants returned to the Clinical Research Center 5--8 days after the biopsy for suture removal. The clinical research notes and personal communication with the participants were used to evaluate the safety of the procedure and verify the incidence of adverse effects. Complications were categorized to major and minor according to the clinical practice guidelines of the Society of Interventional Radiology ([@R17]).

To establish our ability to sample the supraclavicular BAT depot using this method, we conducted the following analysis in a supraclavicular BAT and an abdominal subcutaneous white adipose tissue (WAT) sample (collected using the Bergström technique needle \~10 cm right or left from the umbilicus) using the following techniques:

-   Mitochondrial Respiration: Adipose tissue samples were immediately submerged in a cold pH adjusted preservation buffer and transferred to the laboratory analysis. Respirometry was performed in an O2K oxygraph (Oroboros Instruments, Innsbruck, Austria). Experimental parameters used have been described elsewhere ([@R10], [@R18]). Briefly, BAT and WAT were weighed and suspended in the O2K chamber in 2ml of pH adjusted respiration buffer. Respiratory capacity and function were determined by the addition of substrates, inhibitors and uncouplers. Specifically, the UCP1 inhibitor GDP (30mM final concentration) was titrated into the O2K chamber to confirm the presence and quantify the function of UCP1.

-   **Immunohistochemistry:** Formalin preserved adipose tissue was embedded in paraffin wax. Immunohistochemistry was performed using a standard protocol ([@R19]). Anti-rabbit UCP1 antibody (Cat. No. U6382, Sigma-Aldrich, St Louis, MD, ABC kit and DAB kit Vector laboratories, Inc, Burlingame) were used in protocol. An Olympus microscope (BX41C) with cellSens Viewer 1.5 software (Olympus Soft Imaging Solutions GmbH, Munster, Germany) was used for slide imaging.

-   **Gene expression:** RNA was extracted from adipose tissue using a pure link RNA isolation mini kit Total (Life Technologies, Carlsbad, CA). cDNA was synthesized by High-Capacity RNA-to-cDNA™ Kit (Life Technologies, Carlsbad, CA) and pre-amplified by TaqMan® PreAmp Master Mix Kit (Life Technologies, Carlsbad, CA). Quantitative real-time-PCR analyses were performed on an ABI PRISM 7900HT using the TaqMan® Gene Expression Master Mix (Life Technologies, Carlsbad, CA), pre-amplified cDNA and specific Taqman gene UCP1 expression assays (Hs00222453_m1, Life Technologies, Carlsbad, CA). GAPDH (Hs02758991_g1) was used as the housekeeping gene to normalize the expression of the target gene.

RESULTS AND DISCUSSION {#S3}
======================

The study sample consisted of 23 men, 44±3 years old, BMI 29±2 kg/m^2^ who underwent a total of 43 supraclavicular biopsies. The vast majority of the participants tolerated the biopsy without any major complaints. On one occasion (2.3% of biopsies), the participant developed a subcutaneous hematoma, which fully resolved. On four occasions (9.6% of biopsies), the participants complained of numbness and tingling in the site of the biopsy, which resolved without further complaints.

The amount of supraclavicular BAT obtained using this PET and CT-guided needle biopsy was 100--200 mg of tissue. The amount was enough to conduct quantitative PCR, immunohistochemistry, and mitochondrial respiration analyses. Analyses conducted in one sample confirm that tissue collected had characteristics similar to animal BAT: (1) the gene expression of uncoupling protein 1 (UCP1) was 61 times higher than that of abdominal subcutaneous WAT from the same subject; (2) histology results show minimal UCP1 staining (0.99% strong positive) in the subcutaneous abdominal WAT ([Figure 2a](#F2){ref-type="fig"}) and intense UCP1 staining (22% strong positive) in the supraclavicular BAT ([Figure 2b](#F2){ref-type="fig"}); (3) the supraclavicular BAT samples had a higher uncoupled respiration compared to the abdominal adipose tissue in basal conditions and upon the addition of substrates ([Figure 2c--d](#F2){ref-type="fig"}); and (4) in the supraclavicular BAT sample, O~2~ consumption decreased following the addition of the UCP1 inhibitor GDP, indicating the presence of UCP1 ([Figure 2c](#F2){ref-type="fig"}) ([@R20]).

The proposed method is of significance because it can be safely used to sample the supraclavicular BAT deposit for research purposes. The majority of previous studies that have sample the human BAT used either postmortem specimens ([@R7], [@R12], [@R14]) or samples obtained during surgeries ([@R2], [@R4], [@R6]). However, the fact the subjects sampled were either deceased or had an underlying pathological condition, may limit the generalizability of the results. Other studies conducted a limited number of open biopsies ([@R1], [@R8], [@R9], [@R13]). Although open biopsy techniques can also be used to biopsy human BAT, they are more invasive than the proposed technique.

To the best of our knowledge, this is the first report to describe and evaluate the safety of a minimally invasive method to routinely sample the supraclavicular human BAT depot. Our results demonstrate that the proposed method is well tolerated with only minimal risk. Further, this method yields adequate tissue for molecular and functional analysis of the tissue without damaging its morphological characteristics. Limitations of this method include its high cost, exposure to radiation, and the need for equipment and adequately trained personnel. Adaption of this method from investigators in the area of BAT research may increase the availability of human BAT specimens and accelerate the development of current scientific knowledge.
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![Biopsy procedure\
**(a)** 2-deoxy-2-\[18F\]fluoro-D-glucose (18F-FDG)- Positron Emission Tomography/Computed Tomography image from a study participant. The intense orange color corresponds to metabolically active brown adipose tissue. **(b)** The study participant lying on the table of the computed tomography (CT) procedure room. **(c)** CT scout image corresponding to the supraclavicular area after the insertion of the injection needle to ensure its placement. **(d)** Tubing attached to the 6 mm Bergstrom needle and BD syringe to generate suction. **(e)** The study physician (P.A.) during the biopsy procedure. For [Figures 1a and b](#F1){ref-type="fig"} informed consent to publish was obtained from the study participant.](nihms684206f1){#F1}

![Molecular and functional data supporting the sampling of supraclavicular BAT deposit using the PET/CT guided needle biopsy method\
(**a--b**) Uncoupling protein 1 (UCP1) staining (20x) in a abdominal subcutaneous (a) and supraclavicular adipose (**b**) tissue sample, demonstrating typical characteristic of brown adipose tissue (i.e. intense UCP1 staining and multi-locular cells) in supraclavicular adipose tissue. (**c--d**) Stages of mitochondrial respiration in an abdominal subcutaneous (**c**) and supraclavicular adipose (**d**) tissue sample, indicating a higher uncoupled respiration rate compared to the abdominal adipose tissue in basal conditions and upon the addition of oxidative substrates. GDP: Guanosine diphosphate, CCCP: Carbonyl cyanide m-chlorophenyl hydrazine.](nihms684206f2){#F2}
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